-
Weather News
/ 3 days agoAn exhibit fit for a queen: The fashion of Elizabeth II
During her lifetime, and her 70-year reign as Britain’s monarch, Queen Elizabeth II’s wardrobe was as important diplomatically as any speech...
-
Weather News
/ 3 days agoLive Updates: Trump tells Iran and Israel to “stop ‘shooting'” as ceasefire teeters on war’s 101st day
Frank Andrews , Frank Andrews is a CBS News journalist based in London. Frank Andrews , Add CBS News on Google...
-
Weather News
/ 3 days agoPope Leo denounces what he calls “scourge” of sexual abuse by Catholic clergy
Pope Leo XIV on Monday denounced the “scourge” of sexual violence by Catholic clergy and called for a “culture of care”...
-
Style News
/ 3 days agoGymshark unveils collaboration with Bratz dolls
Gymshark launches a new capsule collection in collaboration with Bratz dolls, aiming to empower women in fitness.Read More
-
MLS
/ 3 days agoFlorentino Perez Wins Presidential Election: What Happens Next for Real Madrid?
The 79-year-old has seen off the challenge from Enrique Riquelme.Read More
-
MLS
/ 3 days ago‘We’ll Evaluate’—New Lamine Yamal Injury Update Ahead of Spain’s World Cup Opener
A hamstring injury picked up in April has threatened to derail Yamal’s first appearance at world soccer’s biggest event.Read More
-
Tech News
/ 3 days agoFive ways Elon Musk’s SpaceX upended Wall Street’s IPO playbook
Elon Musk is bringing his pioneering business style to the IPO world this week when his rocket and satellite maker SpaceX...
-
Weather News
/ 3 days ago6/7: Sunday Morning
Hosted by Jane Pauley: Featured: The Tony-nominated musical “Ragtime”; Steven Spielberg on “Disclosure Day”; GLP-1 medications; college grads’ job search woes;...
-
Weather News
/ 3 days agoConcern of Ukraine war spreading as drone shot down in Latvia, another lands Moldova
Latvia’s military said it shot down a drone that entered the country’s airspace on Monday — the latest in a series...
-
Financial News
/ 3 days agoWeight loss drug maker sinks 25% after new safety data spooks investors
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.Read More





